首页 > 市场调查报告书 > 医疗设备

手术用器具

市场调查报告书

商品编码

1439486

Dilator - 全球市场考量、竞争格局、市场预测 (2030)

Dilators - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 按订单生产 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

简介目录图表

预计 2024 年至 2030 年预测期内，全球扩张器市场规模将以 8.20% 的复合年增长率成长。市场呈现积极的市场成长，主要得益于胃肠道、老年妇女妇科疾病、鼻腔疾病等各领域手术需求的增加，产品开发的重大进展，以及先进扩张器的快速进步，这些都促进了增长2024 -2030 年预测期内扩张器市场的情况。

扩张器市场动态

扩张器市场的主要驱动因素之一是其在各个外科领域的广泛使用。对于因食道癌等胃肠道疾病而导致食道狭窄的人，扩张术可以透过扩大食道来缓解症状。根据美国癌症协会（2022）的数据，预计 2022 年将有 15,530 人（12,410 名男性和 3,120 名女性）死于食道原因。根据世界癌症研究基金会（2018）的数据，2018 年食道癌是男性第 7 位最常见癌症，女性第 13 位最常见癌症。

此外，老年女性子宫颈癌和卵巢癌病例的增加也是推动扩张器市场成长的因素。根据世界卫生组织（WHO）2022年的数据，子宫颈癌是女性第四大常见癌症。

此外，美国癌症协会（2022）的数据显示，子宫颈癌最常见于35岁至44岁的女性，平均诊断年龄为50岁。超过20%的子宫颈癌病例发生在65岁以上的女性身上。

这些患者需要子宫颈扩张器，以便医师扩张子宫颈。因此，由于胃肠道和妇科疾病的盛行率不断增加，扩张器的需求预计将呈现高成长，从而推动扩张器市场在预测期（2024-2030年）的成长，产生正面影响。

除上述因素外，扩张器领域的技术进步，例如改善手术效果的新技术的开发，预计也将有助于扩张器市场的成长。例如，2022 年 5 月，Merit Medical Endotek 宣布推出 Elation5 扩张球囊，这是有史以□□来第一个也是唯一一个五级球囊。 Elation5 旨在在单一球囊导管可用的最宽直径范围内逐步扩张胃肠道狭窄。

然而，产品召回和扩张器高成本等某些因素预计将抑制扩张器市场的成长。

此外，由于作为阻止 COVID-19 传播的必要措施而实施的封锁规定，扩张器市场经历了一段时期的暂时衰退。这段时间的主要措施之一是暂停许多择期手术和门诊。这项措施减少了市场对扩张器的需求，因为在封锁初期，各医疗专科的大量手术被暂停，短时间内限制了市场的成长。话虽如此，由于全球众多 COVID-19 疫苗的批准和管理，随着包括医疗保健服务在内的各个领域的活动恢復，扩张器市场预计将在 2024 年进入復苏阶段。扩张器市场的未来前景预测期间~2030 年是光明的。

扩张器细分市场分析

就扩张器市场的产品类型细分而言，预计在预测期内（2024-2030年）妇科扩张器将在扩张器市场中占据较高份额。这是因为妇科扩张器由阴道扩张器、子宫颈扩张器和许多其他产品组成，并用于各种外科手术。

妇科扩张器在外科手术中非常有用，因为它们可以缓慢地打开子宫颈和阴道，几乎没有不适。由于最终用户对早期准确诊断的需求不断增加，与这些设备相关的专业功能正在促进该产品领域的快速成长。世界各地医院和诊断中心越来越多地采用妇科扩张器也推动了这一成长。

本报告研究和分析了全球扩张器市场，提供市场规模和预测、驱动因素和挑战、公司和产品概况等。

扩张器市场驱动因素
- 各领域对手术的需求不断增加
- 先进扩张器的快速进展
- 产品开发方面的技术进步
扩张器市场的限制与挑战
- 产品召回
- 扩张器的成本非常高
扩张器市场机遇
- 对先进设备的需求不断增加
- 推出针对新兴市场的产品

第5章扩张器市场的波特五力分析

第6章COVID-19对扩张器市场的影响分析

第7章扩张器市场布局

依产品类型
- 妇科扩张器
- 尿道扩张器
- 食道扩张器
- 虹膜扩张器
- 其他
依类型
- 机械
- 气球
依用途
- 诊断
- 治疗
按最终用户
- 医院、诊所
- 医疗保健中心
按地区
- 北美
- 欧洲
- 亚太地区
- 其他领域

第 8 章扩张器市场：全球公司份额分析 - 3 至 5 家主要公司

第 9 章扩张器市场公司与产品概况

Johnson and Johnson (Acclarent, Inc.)
Hebson
CONMED Corporation
Scanlan International
Medtronic
Coloplast (Atos Medical AB)
Teleflex Incorporated
Medpro Medical B.V.
Boston Scientific Corporation
Soul Source Therapeutic Devices, Inc.
Cook
Olympus
GPC Medical Ltd.
Nidhi Meditech Systems
CooperSurgical, Inc.
Hologic, Inc.
MedGyn Products, Inc.
Novo Surgical Inc.
Medicem Group a.s.
Panpac Medical Corp.

第10章KOL观看次数

第 11 章专案方法

第 12 章关于 DelveInsight

第 13 章免责声明与联络我们

简介目录图表

Product Code: DIMDCL0304

Dilators Market By Product Type (Gynecological Dilators, Urethral Dilators, Esophageal Dilators, Iris Dilators, Others), By Type (Mechanical, Balloon), By Application (Diagnostic, Treatment), By End-User (Hospitals And Clinics, Healthcare Centers, Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to rising prevalence of gynecological conditions and rapid evolution of advanced devices

The Global Dilators market is expected to grow at CAGR of 8.20% during the forecast period from 2024 to 2030. The Dilators market is witnessing a positive market growth owing to the growing surgical demand in various fields majorly gastrointestinal, gynecological conditions in geriatric women, nasal conditions, and many others, significant advancement in product development, and rapid evolution of advanced Dilators, thereby contributing to the growth of the Dilators market during the forecast period from 2024-2030.

Dilators Market Dynamics:

One of the main drivers of the Dilators market is their wide application in various surgical fields. For people with esophageal strictures in gastrointestinal conditions like Esophageal cancer, dilation offers relief from symptoms by widening the esophagus. As per the American Cancer Society, 2022, it is estimated that 15,530 deaths (12,410 men and 3,120 women) from Esophageal will occur in 2022. According to the World Cancer Research Fund, 2018, Esophageal cancer is the seventh most commonly occurring cancer in men and the 13th most commonly occurring cancer in women in 2018.

Moreover, the growing cases of cervical & ovarian cancers in geriatric women is another factor responsible for the growth of the Dilators market. As per the data provided by the World Health Organization (WHO) 2022, Cervical cancer is the fourth most common cancer in women.

Moreover, as per the American Cancer Society 2022, Cervical cancers are most frequently diagnosed in women between the ages of 35 and 44 with the average age of diagnosis being 50. More than 20% of cases of cervical cancer are found in women over 65.

These patients require the use of Cervical Dilators to widen the Cervix for the physician. Therefore, the demand for Dilators is set to witness an increased growth owing to the increasing prevalence of growing cases of gastrointestinal and gynecological conditions, thereby positively impacting the dilators market growth during the forecast period (2024-2030).

Along with the factors mentioned above, technological advancements in the field of Dilators such as the development of new techniques to enhance the output of surgeries are also expected to aid in the growth of the Dilators market. For instance, in May 2022, Merit Medical Endotek announced the launch of the Elation5 Dilation Balloon, the first and only 5-stage balloon on the market. Elation5 is designed to incrementally dilate strictures in the gastrointestinal tract with the widest diameter range available on a single balloon catheter.

However, certain factors like product recall and the very high cost of the dilators are expected to restrain the growth of the dilators market.

Moreover, the Dilators market witnessed a period of temporary setback owing to the imposing of the lockdown restrictions as necessary measures to contain the COVID-19 spread. One of the major steps during this was the suspension of numerous elective procedures and outpatient visits which reduced the demand for Dilators in the market as a large number of surgeries across different medical specialties were suspended during the initial lockdown period, thereby limiting the market growth for a short time. Nevertheless, the market for Dilators is in the period of recovery with the resumption of activities across various domains including healthcare services owing to the approval and administration of numerous COVID-19 vaccines across the globe, thereby presenting a positive future outlook for the Dilators market during the forecast period from 2024-2030.

Dilators Market Segment Analysis:

Dilators Market By Product Type (Gynecological Dilators, Urethral Dilators, Esophageal Dilators, Iris Dilators, Others), By Type (Mechanical, Balloon), By Application (Diagnostic, Treatment), By End-User (Hospitals and Clinics, Healthcare Centers, Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the Product Type segment of the Dilators market, the Gynecological Dilators are estimated to hold a higher share in the Dilators market during the forecast period (2024-2030). This can be attributed to the fact that Gynecological Dilators are comprised of Vaginal, Cervical Dilators, and many others and are used in different surgical procedures.

The Gynecological Dilators help in opening the cervix and vagina slowly and with little discomfort for surgical purposes. The specific features associated with these devices contribute to the rapid growth of this product segment which attributes to the growing demand for early and accurate diagnostics among end-users. The growing adoption of Gynecological Dilators by hospitals and diagnostic centers around the world is also driving the growth.

Therefore, the growing demand for disease treatment benefits the segment growth of the Dilators market. Hence, their reliability has constantly increased with time and advancements in the newer generation of devices. Therefore, considering the advantages associated with Gynecological Dilators, this category is expected to generate significant revenue share eventually contributing to the overall growth of the global Dilators market in the forecast period.

North America is expected to dominate the overall Dilators Market:

Among all the regions, North America is expected to account for the largest share in the global Dilators market. Factors such as the growing surgical demand in various fields, significant advancement in product development, the rapid evolution of advanced Dilators, increasing government initiatives, and significant product launches are expected to aid in the growth of the North America Dilators Market.

Furthermore, high disposable income, sophisticated healthcare infrastructure, and increased awareness regarding disease progression and new treatments are also expected to aid in the Dilators market growth in this region.

According to the American Cancer Society 2022, about 19,260 new esophageal cancer cases diagnosed (15,310 in men and 3,950 in women) in 2022.

According to the data of the US Department of Health and Human Services 2022, an estimated 293,394 women were living with cervical cancer in the United States in 2018. As per the same statistics, an estimated 235,081 women were living with ovarian cancer in the United States in 2018.

Therefore, the rising prevalence of various surgeries in the country would result in the rising demand for treatments that make use of Dilators, which in turn would provide a conducive growth environment for the North American Dilators market.

Furthermore, the increased emphasis on product development activities and high interest of device manufacturers in accessing local markets further aid in the growth of the regional markets for Dilators.

Therefore, the interplay of various factors such as the presence of a large patient population, encouraging reimbursement policies as well as new product launches in the region is expected to boost the North America Dilators market during the forecast period.

Dilators Market Key Players:

Some of the key market players operating in the Dilators market include Johnson and Johnson (Acclarent, Inc.), Hebson, CONMED Corporation, Scanlan International, Medtronic, Coloplast (Atos Medical AB), Teleflex Incorporated, Medpro Medical B.V., Boston Scientific Corporation, Soul Source Therapeutic Devices, Inc., Cook, Olympus, GPC Medical Ltd., Nidhi Meditech Systems, CooperSurgical, Inc., Hologic, Inc., MedGyn Products, Inc., Novo Surgical Inc., Medicem Group a.s., Panpac Medical Corp. and others.

Recent Developmental Activities in the Dilators Market:

In November 2019, Hologic, Inc. launched the Definity(TM) cervical dilator, a major advancement for gynecological procedures that uses SureAccess(TM) balloon technology to gently and effortlessly access uterine cavities without a tenaculum, lessening patient discomfort and reducing the risk of perforation during dilation.

In May 2019, Baylis Medical announced the US launch and first clinical use of its ExpanSure(TM) Transseptal Dilation System, used in a left-atrial appendage (LAA) closure case performed at the Cleveland Clinic, in Cleveland, Ohio.

Key Takeaways from the Dilators Market Report Study

Market size analysis for current Dilators market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Dilators market.

Top key product/services/Type developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the global Dilators market.

Various opportunities available for the other competitor in the Dilators market space.

What are the top performing segments in 2023? How these segments will perform in 2030.

Which is the top-performing regions and countries in the current Dilators market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Dilators market growth in the coming future?

Target Audience who can be benefited from this Dilators Market Report Study

Dilators products providers

Research organizations and consulting companies

Dilators-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in Dilators

Various End-users who want to know more about the Dilators market and latest technological developments in the Dilators market.

Frequently Asked Questions for Dilators Market:

1. What are Dilators?

A dilator is a surgical device that is used to induce an expansion of a passage or an opening inside the body.

2. What is the market for Global Dilators?

The Global Dilators market is expected to grow at CAGR of 8.20% during the forecast period from 2024 to 2030.

3. What are the drivers for Global Dilators Market?

The Dilators market is witnessing positive market growth owing to growing surgical demand in various fields majorly gastrointestinal, gynecological conditions in geriatric women, nasal conditions, and many others, significant advancement in product development, and rapid evolution of advanced Dilators, thereby contributing to the growth of the Dilators market during the forecast period from 2024-2030.

4. Who are the key players operating in the Global Dilators Market?

5. Which region has the highest share in Dilators Market?

North America is expected to hold the highest share in the revenue in the Dilators market during the forecast period. Factors such as the rising prevalence of gynecological conditions like infections, growing cases of cervical & ovarian cancers in geriatric women, significant advancement in product development, the rapid evolution of advanced Dilators, increasing government initiatives, and significant product launches are expected to aid in the growth of the North America Dilators Market. Furthermore, high disposable income, sophisticated healthcare infrastructure, and increased awareness regarding disease progression and new treatments are also expected to aid in the Dilators market growth in this region.

1.Dilators Market Report Introduction

2.Dilators Market Executive Summary

2.1 Scope of the Study
2.2 Market at Glance
2.3 Competitive Assessment
2.4 Financial Benchmarking

3. Regulatory and Patent Analysis

3.1 The United States
3.2 Europe
3.3 Japan
3.4 China

4. Dilators Market Key Factors Analysis

4.1 Dilators Market Drivers
- 4.1.1 The growing surgical demand in various fields
- 4.1.2 The rapid evolution of advanced Dilators
- 4.1.3 Technological Advancements in Product Development
4.2 Dilators Market Restraints and Challenges
- 4.2.1 Product recalls
- 4.2.2 The very High Cost of the Dilators
4.3 Dilators Market Opportunities
- 4.3.1 Increasing Demand for Advanced Devices
- 4.3.2 Targeting Emerging Markets for Product Launches

5. Dilators Market Porter's Five Forces Analysis

5.1 Bargaining Power of Suppliers
5.2 Bargaining Power of Consumers
5.3 Threat of New Entrants
5.4 Threat of Substitutes
5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Dilators Market

7. Dilators Market Layout

7.1 By Product Type
- 7.1.1 Gynecological Dilators
- 7.1.2 Urethral Dilators
- 7.1.3 Esophageal Dilators
- 7.1.4 Iris Dilators
- 7.1.5 Others
7.2 By Type
- 7.2.1 Mechanical
- 7.2.2 Balloon
7.3 By Application
- 7.3.1 Diagnostic
- 7.3.2 Treatment
7.4 By End User
- 7.4.1 Hospitals and Clinics
- 7.4.2 Healthcare Centers
- 7.4.3 Others
7.5 By Geography
- 7.5.1 North America
  - 7.5.1.1 North America Dilators Market, by Product Type
  - 7.5.1.2 North America Dilators Market, by Type
  - 7.5.1.3 North America Dilators Market, by Application
  - 7.5.1.4 North America Dilators Market, by End User
  - 7.5.1.5 North America Dilators Market, by Country
  - 7.5.1.5.1 United States
  - 7.5.1.5.2 Canada
  - 7.5.1.5.3 Mexico
- 7.5.2 Europe
  - 7.5.2.1 Europe Dilators Market, by Product Type
  - 7.5.2.2 Europe Dilators Market, by Type
  - 7.5.2.3 Europe Dilators Market, by Application
  - 7.5.2.4 Europe Dilators Market, by End User
  - 7.5.2.5 Europe Dilators Market, by Country
  - 7.5.2.5.1 France
  - 7.5.2.5.2 Germany
  - 7.5.2.5.3 United Kingdom
  - 7.5.2.5.4 Italy
  - 7.5.2.5.5 Spain
  - 7.5.2.5.6 Russia
  - 7.5.2.5.7 Rest of Europe
- 7.5.3 Asia-Pacific
  - 7.5.3.1 Asia-Pacific Dilators Market, by Product Type
  - 7.5.3.2 Asia-Pacific Dilators Market, by Type
  - 7.5.3.3 Asia-Pacific Dilators Market, by Application
  - 7.5.3.4 Asia-Pacific Dilators Market, by End User
  - 7.5.3.5 Asia-Pacific Dilators Market, by Country
  - 7.5.3.5.1 China
  - 7.5.3.5.2 Japan
  - 7.5.3.5.3 India
  - 7.5.3.5.4 Australia
  - 7.5.3.5.5 South Korea
  - 7.5.3.5.6 Rest of Asia Pacific
- 7.5.4 Rest of the World (RoW)
  - 7.5.4.1 RoW Dilators Market, by Product Type
  - 7.5.4.2 RoW Dilators Market, by Type
  - 7.5.4.3 RoW Dilators Market, by Application
  - 7.5.4.4 RoW Dilators Market, by End User
  - 7.5.4.5 RoW Dilators Market, by Region
  - 7.5.4.5.1 Middle East
  - 7.5.4.5.2 Africa
  - 7.5.4.5.3 South America

8. Dilators Market Global Company Share Analysis - Key 3-5 Companies

9. Dilators Market Company and Product Profiles

9.1 Johnson and Johnson (Acclarent, Inc.)
- 9.1.1. Company Overview
- 9.1.2. Company Snapshot
- 9.1.3. Financial Overview
- 9.1.4 Product Listing
- 9.1.5. Entropy
9.2 Hebson
- 9.2.1. Company Overview
- 9.2.2. Company Snapshot
- 9.2.3. Financial Overview
- 9.2.4 Product Listing
- 9.2.5. Entropy
9.3 CONMED Corporation
- 9.3.1. Company Overview
- 9.3.2. Company Snapshot
- 9.3.3. Financial Overview
- 9.3.4 Product Listing
- 9.3.5. Entropy
9.4 Scanlan International
- 9.4.1. Company Overview
- 9.4.2. Company Snapshot
- 9.4.3. Financial Overview
- 9.4.4 Product Listing
- 9.4.5. Entropy
9.5 Medtronic
- 9.5.1. Company Overview
- 9.5.2. Company Snapshot
- 9.5.3. Financial Overview
- 9.5.4 Product Listing
- 9.5.5. Entropy
9.6 Coloplast (Atos Medical AB)
- 9.6.1. Company Overview
- 9.6.2. Company Snapshot
- 9.6.3. Financial Overview
- 9.6.4 Product Listing
- 9.6.5. Entropy
9.7 Teleflex Incorporated
- 9.7.1. Company Overview
- 9.7.2. Company Snapshot
- 9.7.3. Financial Overview
- 9.7.4 Product Listing
- 9.7.5. Entropy
9.8 Medpro Medical B.V.
- 9.8.1. Company Overview
- 9.8.2. Company Snapshot
- 9.8.3. Financial Overview
- 9.8.4 Product Listing
- 9.8.5. Entropy
9.9 Boston Scientific Corporation
- 9.9.1. Company Overview
- 9.9.2. Company Snapshot
- 9.9.3. Financial Overview
- 9.9.4 Product Listing
- 9.9.5. Entropy
9.10 Soul Source Therapeutic Devices, Inc.
- 9.10.1. Company Overview
- 9.10.2. Company Snapshot
- 9.10.3. Financial Overview
- 9.10.4 Product Listing
- 9.10.5. Entropy
9.11 Cook
- 9.11.1. Company Overview
- 9.11.2. Company Snapshot
- 9.11.3. Financial Overview
- 9.11.4 Product Listing
- 9.11.5. Entropy
9.12 Olympus
- 9.12.1. Company Overview
- 9.12.2. Company Snapshot
- 9.12.3. Financial Overview
- 9.12.4 Product Listing
- 9.12.5. Entropy
9.13 GPC Medical Ltd.
- 9.13.1. Company Overview
- 9.13.2. Company Snapshot
- 9.13.3. Financial Overview
- 9.13.4 Product Listing
- 9.13.5. Entropy
9.14 Nidhi Meditech Systems
- 9.14.1. Company Overview
- 9.14.2. Company Snapshot
- 9.14.3. Financial Overview
- 9.14.4 Product Listing
- 9.14.5. Entropy
9.15 CooperSurgical, Inc.
- 9.15.1. Company Overview
- 9.15.2. Company Snapshot
- 9.15.3. Financial Overview
- 9.15.4 Product Listing
9.16 Hologic, Inc.
- 9.16.1. Company Overview
- 9.16.2. Company Snapshot
- 9.16.3. Financial Overview
- 9.16.4 Product Listing
- 9.16.5. Entropy
9.17 MedGyn Products, Inc.
- 9.17.1. Company Overview
- 9.17.2. Company Snapshot
- 9.17.3. Financial Overview
- 9.17.4 Product Listing
- 9.17.5. Entropy
9.18 Novo Surgical Inc.
- 9.18.1. Company Overview
- 9.18.2. Company Snapshot
- 9.18.3. Financial Overview
- 9.18.4 Product Listing
- 9.18.5. Entropy
9.19 Medicem Group a.s.
- 9.19.1. Company Overview
- 9.19.2. Company Snapshot
- 9.19.3. Financial Overview
- 9.19.4 Product Listing
- 9.19.5. Entropy
9.20 Panpac Medical Corp.
- 9.20.1. Company Overview
- 9.20.2. Company Snapshot
- 9.20.3. Financial Overview
- 9.20.4 Product Listing
- 9.20.5. Entropy